Sinopharm umbrella will guarantee rapid IP applications. That is certainly a difference between ours and their system, once backed by the right channels, progress in IP protection is a much faster affair.
I would therefore not stress about those hurdles.
A positive CACLP outcome will pave the way for quick commercialisation IMO.
DEALROOM
New Feature Announcement!
We’re excited to introduce the DealRoom portal, now live on site, providing users with exciting access to private equity opportunities for both pre-IPO and publicly listed companies.
See full details by selecting the new menu item named 'DealRoom' on our main menu bar or click below.
Stay ahead of the market, with HotCopper.